Predictive factors for better bypass patency and limb salvage after prosthetic above-knee bypass reconstruction.

[1]  Dong-Ik Kim,et al.  Comparison of long-term results of above-the-knee femoro-popliteal bypass with autogenous vein and polytetrafluoroethylene grafts , 2014, Annals of surgical treatment and research.

[2]  Young Wook Kim,et al.  Comparisons between prosthetic vascular graft and saphenous vein graft in femoro-popliteal bypass , 2014, Annals of surgical treatment and research.

[3]  O. Al-Nouri,et al.  Aspirin usage is associated with improved prosthetic infrainguinal bypass graft patency , 2014, Vascular.

[4]  A. Davies,et al.  Chapter IV: Treatment of critical limb ischaemia. , 2011, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[5]  P. Castelli,et al.  A multicenter comparison between autologous saphenous vein and heparin-bonded expanded polytetrafluoroethylene (ePTFE) graft in the treatment of critical limb ischemia in diabetics. , 2011, Journal of vascular surgery.

[6]  H. Redmond,et al.  Predictors of Time to Graft Failure Following Infrainguinal Arterial Reconstruction , 2011 .

[7]  M. Rotondo,et al.  Results of the randomized, placebo-controlled clopidogrel and acetylsalicylic acid in bypass surgery for peripheral arterial disease (CASPAR) trial. , 2010, Journal of vascular surgery.

[8]  C. D. Owens,et al.  Risk factors for lower-extremity vein graft failure. , 2009, Seminars in vascular surgery.

[9]  R. Foxall,et al.  The effects of increasing obesity on outcomes of vascular surgery. , 2009, Annals of vascular surgery.

[10]  J. van der Palen,et al.  Dacron or ePTFE for femoro-popliteal above-knee bypass grafting: short- and long-term results of a multicentre randomised trial. , 2009, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[11]  S. Solaković,et al.  Femoro-popliteal bypass above knee with saphenous vein vs synthetic graft. , 2008, Bosnian journal of basic medical sciences.

[12]  P. Libby,et al.  Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. , 2008, The New England journal of medicine.

[13]  W. Henderson,et al.  Factors associated with early failure of infrainguinal lower extremity arterial bypass. , 2008, Journal of vascular surgery.

[14]  H. Myhre,et al.  Dacron or PTFE for Above-knee Femoropopliteal Bypass. A Multicenter Randomised Study , 2007 .

[15]  E. Matros,et al.  Refinement of survival prediction in patients undergoing lower extremity bypass surgery: stratification by chronic kidney disease classification. , 2007, Journal of vascular surgery.

[16]  Arash Mohammadi Tofigh,et al.  Comparing vein with collagen impregnated woven polyester prosthesis in above-knee femoropopliteal bypass grafting. , 2007, International journal of surgery.

[17]  M. Romiti,et al.  Meta-analysis of femoropopliteal bypass grafts for lower extremity arterial insufficiency. , 2006, Journal of vascular surgery.

[18]  Scott A Berceli,et al.  Results of PREVENT III: a multicenter, randomized trial of edifoligide for the prevention of vein graft failure in lower extremity bypass surgery. , 2006, Journal of vascular surgery.

[19]  E. Laxdal,et al.  The impact of comorbidity on long-term results of above-knee prosthetic femoropopliteal bypass for intermittent claudication. , 2005, International angiology : a journal of the International Union of Angiology.

[20]  R. Peters,et al.  Smoking and the patency of lower extremity bypass grafts: a meta-analysis. , 2005, Journal of vascular surgery.

[21]  M. Björck,et al.  Long-term results of above knee femoro-popliteal bypass depend on indication for surgery and graft-material. , 2005, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[22]  K. Eagle,et al.  Patients undergoing infrainguinal bypass to treat atherosclerotic vascular disease are underprescribed cardioprotective medications: effect on graft patency, limb salvage, and mortality. , 2004, Journal of vascular surgery.

[23]  R. Hassen-Khodja,et al.  Long-term Outcome of Femoral Above-knee Popliteal Artery Bypass Using Autologous Saphenous Vein Versus Expanded Polytetrafluoroethylene Grafts , 2003, Annals of vascular surgery.

[24]  D. Raithel,et al.  Graft patency and clinical outcome of femorodistal arterial reconstruction in diabetic and non-diabetic patients: results of a multicentre comparative analysis. , 2003, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[25]  AndrewJ. S. Coats.  MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trial , 2002, The Lancet.

[26]  S. Post,et al.  Dacron vs. polytetrafluoroethylene grafts for femoropopliteal bypass: a prospective randomised multicentre trial. , 2001, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[27]  W. Lang,et al.  Der supragenuale PTFE-Bypass , 2001, Gefässchirurgie.

[28]  C. McCollum,et al.  Heparin-bonded Dacron or polytetrafluoroethylene for femoropopliteal bypass grafting: a multicenter trial. , 2001, Journal of vascular surgery.

[29]  O. Tobolski,et al.  Thrombosiertes Aneurysma der V. poplitea als Ursache rezidivierender Lungenembolien , 2001, Gefässchirurgie.

[30]  Willard C. Johnson,et al.  A comparative evaluation of polytetrafluoroethylene, umbilical vein, and saphenous vein bypass grafts for femoral-popliteal above-knee revascularization: a prospective randomized Department of Veterans Affairs cooperative study. , 2000, Journal of vascular surgery.

[31]  J. H. van Bockel,et al.  A prospective randomized trial comparing vein with polytetrafluoroethylene in above-knee femoropopliteal bypass grafting. , 2000, Journal of vascular surgery.

[32]  R. Green,et al.  Prosthetic above-knee femoropopliteal bypass grafting: five-year results of a randomized trial. , 2000, Journal of vascular surgery.

[33]  J. Kjekshus,et al.  Effect of simvastatin on ischemic signs and symptoms in the Scandinavian simvastatin survival study (4S). , 1998, The American journal of cardiology.

[34]  Y. Wilson,et al.  Preferential use of vein for above-knee femoropopliteal grafts. , 1995, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[35]  Archie Jp,et al.  Femoropopliteal bypass with either adequate ipsilateral reversed saphenous vein or obligatory polytetrafluoroethylene. , 1994 .

[36]  B. Hopkinson,et al.  Obesity as a risk factor in major reconstructive vascular surgery. , 1994, European journal of vascular surgery.

[37]  P. Stonebridge,et al.  Above-knee femoropopliteal bypass grafts and the consequences of graft failure. , 1993, Annals of the Royal College of Surgeons of England.

[38]  D. Buckley,et al.  Polytetrafluoroethylene in above-knee arterial bypass surgery for critical ischemia. , 1992, American journal of surgery.

[39]  R. Shukla,et al.  Preferential use of ePTFE for above-knee femoropopliteal bypass grafts , 1990, Annals of vascular surgery.

[40]  T. O'donnell,et al.  Long-term results with the above-knee popliteal expanded polytetrafluoroethylene graft. , 1990, Journal of vascular surgery.

[41]  J. Michaels,et al.  Choice of material for above‐knee femoropopliteal bypass graft , 1989, The British journal of surgery.

[42]  Daniel J. Bertges,et al.  Factors associated with amputation or graft occlusion one year after lower extremity bypass in northern New England. , 2010, Annals of vascular surgery.

[43]  A. Morabito,et al.  Long-Term Prognosis of Diabetic Patients With Critical Limb Ischemia , 2009, Diabetes Care.

[44]  A. Bradbury,et al.  TASC II document on the management of peripheral arterial disease. , 2007, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[45]  L. Norgren,et al.  Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). , 2007, Journal of vascular surgery.

[46]  J. Allenberg,et al.  High prevalence of peripheral arterial disease and co-morbidity in 6880 primary care patients: cross-sectional study. , 2004, Atherosclerosis.

[47]  J. H. van Bockel,et al.  Vein versus polytetrafluoroethylene in above-knee femoropopliteal bypass grafting: five-year results of a randomized controlled trial. , 2003, Journal of vascular surgery.

[48]  S. Yusuf.  MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20536 high-risk individuals: a randomised placebo-controlled trial. Commentary , 2002 .

[49]  T Matsumoto,et al.  Prosthetic above-knee femoropopliteal bypass grafting: results of a multicenter randomized prospective trial. Above-Knee Femoropopliteal Study Group. , 1997, Journal of vascular surgery.

[50]  S. Gutschi,et al.  [Femoropopliteal vascular replacement: vein, ePTFE or ovine collagen?]. , 1996, Zentralblatt fur Chirurgie.

[51]  V. Bernhard,et al.  Six-year prospective multicenter randomized comparison of autologous saphenous vein and expanded polytetrafluoroethylene grafts in infrainguinal arterial reconstructions. , 1986, Journal of vascular surgery.

[52]  M. Webster,et al.  Expanded polytetrafluoroethylene femoropopliteal grafts: forty-eight-month follow-up. , 1981, Surgery.